Indication
Multiple endocrine neoplasia
Multiple endocrine neoplasia refers to a group of rare, inherited autosomal dominant syndromes characterized by the development of benign or malignant tumors in two or more endocrine glands. Read more about Multiple endocrine neoplasia
217 drugs 140 manufacturers
Drugs that treat it
Common Multiple endocrine neoplasia therapies.
RANITIDINE HCL
CIMETIDINE (cimetidine HCl)
CIMETIDINE (cimetidine HCl)
PEPCID (famotidine)
ACID REDUCER (ranitidine HCl)
FAMOTIDINE (famotidine/PF)
HEARTBURN RELIEF (ranitidine HCl)
RANITIDINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMultiple endocrine neoplasia refers to a group of rare, inherited autosomal dominant syndromes characterized by the development of benign or malignant tumors in two or more endocrine glands.
Primarily affecting hormone-producing tissues, these disorders commonly involve the parathyroid glands, pituitary gland, endocrine pancreas, thyroid gland, and adrenal glands.
Pathophysiologically driven by germline variants—most notably in tumor suppressor genes such as *MEN1* or proto-oncogenes such as *RET*—these conditions lead to cellular hyperplasia, neoplastic transformation, and autonomous hormone hypersecretion.
Clinically, affected individuals present with manifestations of hormonal excess and tumor mass effect, frequently including hyperparathyroidism, medullary thyroid carcinoma, and pheochromocytoma depending on the specific syndrome classification.
- nih.gov
Multiple endocrine neoplasia refers to a group of rare, inherited autosomal dominant syndromes characterized by the development of benign or malignant tumors in two or more endocrine glands Clinically, affected individuals present with manifestations of hormonal excess and tumor mass effect, frequently including hyperparathyroidism, medullary thyroid carcinoma, and pheochromocytoma depending on the specific syndrome classification
- nih.gov
Multiple endocrine neoplasia refers to a group of rare, inherited autosomal dominant syndromes characterized by the development of benign or malignant tumors in two or more endocrine glands Primarily affecting hormone-producing tissues, these disorders commonly involve the parathyroid glands, pituitary gland, endocrine pancreas, thyroid gland, and adrenal glands
- medlineplus.gov
Multiple endocrine neoplasia refers to a group of rare, inherited autosomal dominant syndromes characterized by the development of benign or malignant tumors in two or more endocrine glands
- medlineplus.gov
Primarily affecting hormone-producing tissues, these disorders commonly involve the parathyroid glands, pituitary gland, endocrine pancreas, thyroid gland, and adrenal glands Clinically, affected individuals present with manifestations of hormonal excess and tumor mass effect, frequently including hyperparathyroidism, medullary thyroid carcinoma, and pheochromocytoma depending on the specific syndrome classification
- medlineplus.gov
Pathophysiologically driven by germline variants—most notably in tumor suppressor genes such as *MEN1* or proto-oncogenes such as *RET*—these conditions lead to cellular hyperplasia, neoplastic transformation, and autonomous hormone hypersecretion
- cancer.gov
Pathophysiologically driven by germline variants—most notably in tumor suppressor genes such as *MEN1* or proto-oncogenes such as *RET*—these conditions lead to cellular hyperplasia, neoplastic transformation, and autonomous hormone hypersecretion
Personalize your experience
Follow Multiple endocrine neoplasia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.